PRStrategy
Media Relations and Thought Leadership
Global, Clinical, Public
AC Immune is an international company on Nasdaq with broad pipeline in neurodegenerative diseases. The company has partnerships with leading international pharmaceutical companies for development of AD treatments and was impacted by recent industry trial failures. The goal was to raise visibility as a thought leader in neurodegenerative diseases – highlighting the company’s roadmap to success in AD and increase visibility in national, business and trade publications in the U.S.
LHS Solution
- Increase AC Immune’s brand awareness throughout the U.S. aiming for high profile media outlets while building and cementing relationships with top journalists
- Build awareness of AC Immune’s diversified therapeutic and diagnostic pipeline, as well as the company’s mission for finding a cure for Alzheimer’s and other neuro diseases
- Position CEO as a major thought leader/expert in the neurodegenerative disease space
- Differentiate AC Immune from its competitors in the marketplace through careful, artful message crafting
Results
- Cohesive, integrated communication strategy plan with flawless execution
- Top mentions and original articles in Forbes, Fortune, Reuters, PharmaVoice, Endpoints, FierceBiotech, In Vivo, BioWorld, BioSpace, STAT and Authority Magazine
- Life Science Leader cover story
- Secured 21 top-tier interviews, including with The Wall Street Journal, and Financial Times
- Solidify reputation as having one of the largest neurodegenerative disease piplelines targeting hallmarks of AD and PD
- Secured CEO as expert in neurodegenerative disease space, building reputation for the company and increasing visibility among media and other target audiences
